Table 2. Clinical characteristics of patients.
Normal (N=30) | PCOS (N=30) | P-value | |
Age (years) | 30.60 ± 1.21 | 29.6 ± 1.15 | NS |
BMI (kg/m2) | 21.31± 0.81 | 22.06 ± 0.79 | NS |
FSH (mIU/ml) | 6.53±0.72 | 5.21± 0.92 | <0.05 |
LH (mIU/ml) | 6.30 ± 1.14 | 11.91± 2.16 | <0.001 |
Basal LH/FSH | 0.95 ± 0.02 | 2.23 ± 0.07 | <0.001 |
E2 (pg/ml) | 44.5 ± 4.38 | 69.82 ± 9.8 | NS |
Testosterone (ng/ml) | 0.33 ± 0.05 | 0.73 ± 0.05 | <0.001 |
Progesterone (ng/ml) | 0.58 ± 0.26 | 0.71 ± 0.13 | NS |
Antral follicle count | 11.2±1.32 | 23.1±2.71 | <0.001 |
Total FSH administration (IU) | 1667±245.1 | 1589±164.2 | NS |
Oocytes obtained | 8.6 ± 3.01 | 17.8±6.24 | <0.001 |
Data are the mean ± SEM, NS, not statistically significant.
BMI, body mass index; E2, oestradiol; FSH, follicle-stimulating hormone;
LH, luteotropic hormone; PCOS, polycystic ovary syndrome